Advertisement
Organisation › Details
Phagenesis Ltd.
Start | 2016-09-01 existent | |
Industry | medical device | |
Industry 2 | Phagenyx® medical device | |
Person | Krickl, Reinhard (Phagenesis 201609 CEO) | |
Person 2 | Stuge, Örn (Aleva Neurotherapeutics 201108 Chairmen Board of Directors) | |
Region | Manchester, Greater Manchester | |
Country | United Kingdom (GB) | |
Street | Unit 18, Enterprise House Manchester Science Park | |
City | M15 6SE Manchester | |
Tel | +44-161-820-4525 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Record changed: 2019-07-13 |
Advertisement
More documents for Nestlé (Group)
- [1] Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024"....
- [2] Aimmune Therapeutics, Inc.. (11/1/18). "Press Release: Aimmune Therapeutics to Participate in Upcoming Investor Conferences". Brisbane, CA....
- [3] Aimmune Therapeutics, Inc.. (6/11/18). "Press Release: Aimmune Therapeutics Appoints Dr. Jayson Dallas as CEO". Brisbane, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top